Cenicriviroc

( DrugBank: Cenicriviroc / KEGG DRUG: Cenicriviroc )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
94	原発性硬化性胆管炎	1

94. 原発性硬化性胆管炎

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02653625 (ClinicalTrials.gov)	March 14, 2016	8/1/2016	PERSEUS: Preliminary Efficacy and Safety of Cenicrivirocin Adult Participants With Primary Sclerosin ...	PERSEUS: A Phase 2 Proof of Concept Study Investigating the Preliminary Efficacy and Safety of Cenic ...	Primary Sclerosing Cholangitis	Drug: Cenicriviroc 150 mg	Tobira Therapeutics, Inc.	NULL	Completed	18 Years	75 Years	All	24	Phase 2	United States;Canada

First Previous1Next Last